Location History:
- Kaiseraugst, CH (1982)
- Rheinfelden, CH (1988)
Company Filing History:
Years Active: 1982-1988
Title: Innovations by Kasper F Burri
Introduction
Kasper F Burri is a notable inventor based in Kaiseraugst, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new compounds with therapeutic applications. With a total of 2 patents to his name, Burri's work has the potential to impact the treatment of various infectious diseases.
Latest Patents
Among his latest patents, Burri has developed glycerin derivatives that inhibit blood platelet activating factor (PAF). These derivatives are described by the formula ##STR1##, wherein the residues R.sup.1, R.sup.2, and R.sup.3 have specific significance as detailed in the patent description. Additionally, he has worked on amoxicillin derivatives, specifically the compound 6-[D(-)alpha-amino-phenylacetamido]penicillanic acid. This compound, along with its salts or hydrates, features a substituted amino group with a 5 to 6-membered heterocyclic ring, making it useful as an antibacterial therapeutic agent against both Gram-positive and Gram-negative bacteria.
Career Highlights
Kasper F Burri is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this esteemed organization has allowed him to focus on innovative solutions that address critical health challenges.
Collaborations
Throughout his career, Burri has collaborated with notable colleagues, including Richard Barner and Jean-Marie Cassal. These partnerships have fostered an environment of creativity and innovation, leading to the development of impactful pharmaceutical products.
Conclusion
Kasper F Burri's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.